Symbols / A Stock $135.98 +0.33% Agilent Technologies, Inc.

Healthcare • Diagnostics & Research • United States • NYQ
A (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Diagnostics & Research
CEO Mr. Padraig McDonnell
Exch · Country NYQ · United States
Market Cap 38.38B
Enterprise Value 39.92B
Income 1.41B
Sales 7.23B
FCF (ttm) 933.37M
Book/sh 25.24
Cash/sh 6.40
Employees 18,000
Insider 10d —
IPO Nov 18, 1999
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 20.20%
P/E 27.31
Forward P/E 20.60
PEG 1.33
P/S 5.31
P/B 5.39
P/C —
EV/EBITDA 19.75
EV/Sales 5.52
Quick Ratio 1.46
Current Ratio 2.10
Debt/Eq 47.11
LT Debt/Eq —
EPS (ttm) 4.98
EPS next Y 6.60
EPS Growth 60.00%
Revenue Growth 10.00%
EPS Gr Q/Q 57.70%
Rev Gr Q/Q —
Earnings (next) 2026-08-26
Earnings (prior) 2026-05-27
ROA 8.64%
ROE 21.33%
ROIC —
Gross Margin 52.74%
Oper. Margin 21.74%
Profit Margin 19.55%
Shs Outstand 282.22M
Shs Float 281.26M
Insider Own 0.19%
Instit Own 94.19%
Short Float 2.21%
Short Ratio 2.66
Short Interest 5.50M
52W High 160.27
vs 52W High -15.16%
52W Low 108.35
vs 52W Low 25.50%
Beta 1.22
Impl. Vol. 0.39%
Rel Volume 1.19
Avg Volume 2.25M
Volume 2.68M
Target (mean) $161.31
Tgt Median $159.50
Tgt Low $144.00
Tgt High $185.00
# Analysts 16
Recom Strong_buy
Prev Close $135.53
Price $135.98
Change 0.33%
About

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$161.31
Mean price target
2. Current target
$135.98
Latest analyst target
3. DCF / Fair value
$59.53
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$135.98
Low
$144.00
High
$185.00
Mean
$161.31

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-28 main RBC Capital Outperform → Outperform $155
2026-05-28 main TD Cowen Buy → Buy $155
2026-05-28 main Barclays Overweight → Overweight $145
2026-05-28 main Wells Fargo Overweight → Overweight $160
2026-05-28 up B of A Securities Neutral → Buy $145
2026-05-27 init RBC Capital — → Outperform $153
2026-05-26 main Baird Outperform → Outperform $156
2026-04-28 reit Keybanc Sector Weight → Sector Weight —
2026-04-14 main Barclays Overweight → Overweight $140
2026-04-13 main TD Cowen Buy → Buy $147
2026-04-06 main Evercore ISI Group Outperform → Outperform $140
2026-03-03 main Morgan Stanley Overweight → Overweight $160
2026-02-26 main UBS Buy → Buy $165
2026-02-26 main TD Cowen Buy → Buy $157
2026-02-26 main Wells Fargo Overweight → Overweight $165
2026-02-26 main Barclays Overweight → Overweight $150
2026-01-20 init HSBC — → Buy $180
2026-01-05 up Evercore ISI Group In-Line → Outperform $160
2025-12-15 up Barclays Equal-Weight → Overweight $165
2025-12-09 init Goldman Sachs — → Buy $170
News
RSS: Latest A news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-05-19 BUCKNER MICHAEL STEVEN Officer — 8,872 $0.00 $0
2026-03-19 ANAND MALA Director — 2,158 $111.75 $241,156
2026-03-19 BRAWLEY OTIS W Director — 3,046 $111.75 $340,390
2026-03-19 KOH BOON HWEE Director — 2,158 $111.75 $241,156
2026-03-19 PODOLSKY DANIEL K Director — 2,158 $111.75 $241,156
2026-03-19 SORIOT PASCAL Director — 2,158 $111.75 $241,156
2026-03-19 WILSON DOW R Director — 2,158 $111.75 $241,156
2026-03-19 BROWN JUDY LYNNE GAWLIK Director — 2,158 $111.75 $241,156
2026-03-19 DOLSTEN MIKAEL G Director — 2,158 $111.75 $241,156
2026-03-19 RATAJ SUE H Director — 2,158 $111.75 $241,156
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-10-31 2024-10-31 2023-10-31 2022-10-31
Total Revenue
6,948.00
+6.73%
6,510.00
-4.73%
6,833.00
-0.22%
6,848.00
Operating Revenue
6,948.00
+6.73%
6,510.00
-4.73%
6,833.00
-0.22%
6,848.00
Cost Of Revenue
3,305.00
+11.09%
2,975.00
-11.67%
3,368.00
+7.74%
3,126.00
Reconciled Cost Of Revenue
3,305.00
+11.09%
2,975.00
-11.67%
3,368.00
+7.74%
3,126.00
Gross Profit
3,643.00
+3.06%
3,535.00
+2.02%
3,465.00
-6.90%
3,722.00
Operating Expense
2,164.00
+5.72%
2,047.00
-3.22%
2,115.00
+0.52%
2,104.00
Research And Development
455.00
-5.01%
479.00
-0.42%
481.00
+3.00%
467.00
Selling General And Administration
1,709.00
+8.99%
1,568.00
-4.04%
1,634.00
-0.18%
1,637.00
Total Expenses
5,469.00
+8.90%
5,022.00
-8.41%
5,483.00
+4.84%
5,230.00
Operating Income
1,479.00
-0.60%
1,488.00
+10.22%
1,350.00
-16.56%
1,618.00
Total Operating Income As Reported
1,479.00
-0.60%
1,488.00
+10.22%
1,350.00
-16.56%
1,618.00
EBITDA
1,835.00
-2.08%
1,874.00
+9.91%
1,705.00
-10.50%
1,905.00
Normalized EBITDA
1,835.00
-2.08%
1,874.00
+9.91%
1,705.00
-10.50%
1,905.00
Reconciled Depreciation
288.00
+12.06%
257.00
-5.17%
271.00
-14.51%
317.00
EBIT
1,547.00
-4.33%
1,617.00
+12.76%
1,434.00
-9.70%
1,588.00
Net Income
1,303.00
+1.09%
1,289.00
+3.95%
1,240.00
-1.12%
1,254.00
Pretax Income
1,435.00
-5.65%
1,521.00
+13.59%
1,339.00
-10.97%
1,504.00
Net Non Operating Interest Income Expense
-50.00
-212.50%
-16.00
+63.64%
-44.00
+41.33%
-75.00
Interest Expense Non Operating
112.00
+16.67%
96.00
+1.05%
95.00
+13.10%
84.00
Net Interest Income
-50.00
-212.50%
-16.00
+63.64%
-44.00
+41.33%
-75.00
Interest Expense
112.00
+16.67%
96.00
+1.05%
95.00
+13.10%
84.00
Interest Income Non Operating
62.00
-22.50%
80.00
+56.86%
51.00
+466.67%
9.00
Interest Income
62.00
-22.50%
80.00
+56.86%
51.00
+466.67%
9.00
Other Income Expense
6.00
-87.76%
49.00
+48.48%
33.00
+184.62%
-39.00
Other Non Operating Income Expenses
6.00
-87.76%
49.00
+48.48%
33.00
+184.62%
-39.00
Tax Provision
132.00
-43.10%
232.00
+134.34%
99.00
-60.40%
250.00
Tax Rate For Calcs
0.00
-39.87%
0.00
+106.76%
0.00
-55.42%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
1,303.00
+1.09%
1,289.00
+3.95%
1,240.00
-1.12%
1,254.00
Net Income From Continuing Operation Net Minority Interest
1,303.00
+1.09%
1,289.00
+3.95%
1,240.00
-1.12%
1,254.00
Net Income From Continuing And Discontinued Operation
1,303.00
+1.09%
1,289.00
+3.95%
1,240.00
-1.12%
1,254.00
Net Income Continuous Operations
1,303.00
+1.09%
1,289.00
+3.95%
1,240.00
-1.12%
1,254.00
Normalized Income
1,303.00
+1.09%
1,289.00
+3.95%
1,240.00
-1.12%
1,254.00
Net Income Common Stockholders
1,303.00
+1.09%
1,289.00
+3.95%
1,240.00
-1.12%
1,254.00
Diluted EPS
4.57
+3.16%
4.43
+5.73%
4.19
+0.24%
4.18
Basic EPS
4.59
+3.38%
4.44
+5.21%
4.22
+0.72%
4.19
Basic Average Shares
284.00
-2.07%
290.00
-1.36%
294.00
-1.67%
299.00
Diluted Average Shares
285.00
-2.06%
291.00
-1.69%
296.00
-1.33%
300.00
Diluted NI Availto Com Stockholders
1,303.00
+1.09%
1,289.00
+3.95%
1,240.00
-1.12%
1,254.00
Line Item Trend 2025-10-31 2024-10-31 2023-10-31 2022-10-31
Total Assets
12,727.00
+7.44%
11,846.00
+10.06%
10,763.00
+2.19%
10,532.00
Current Assets
4,594.00
+16.04%
3,959.00
-5.42%
4,186.00
+10.80%
3,778.00
Cash Cash Equivalents And Short Term Investments
1,789.00
+34.61%
1,329.00
-16.42%
1,590.00
+51.00%
1,053.00
Cash And Cash Equivalents
1,789.00
+34.61%
1,329.00
-16.42%
1,590.00
+51.00%
1,053.00
Other Short Term Investments
—
—
—
0.00
Receivables
1,487.00
+12.31%
1,324.00
+2.56%
1,291.00
-8.11%
1,405.00
Accounts Receivable
1,487.00
+12.31%
1,324.00
+2.56%
1,291.00
-8.11%
1,405.00
Inventory
1,025.00
+5.45%
972.00
-5.72%
1,031.00
-0.67%
1,038.00
Raw Materials
478.00
+6.46%
449.00
-2.60%
461.00
-4.55%
483.00
Finished Goods
547.00
+4.59%
523.00
-8.25%
570.00
+2.70%
555.00
Other Current Assets
293.00
-12.28%
334.00
+21.90%
274.00
-2.84%
282.00
Total Non Current Assets
8,133.00
+3.12%
7,887.00
+19.92%
6,577.00
-2.62%
6,754.00
Net PPE
2,023.00
+13.78%
1,778.00
+40.00%
1,270.00
+15.45%
1,100.00
Gross PPE
3,446.00
+11.81%
3,082.00
+23.63%
2,493.00
+10.90%
2,248.00
Accumulated Depreciation
-1,423.00
-9.13%
-1,304.00
-6.62%
-1,223.00
-6.53%
-1,148.00
Properties
0.00
0.00
0.00
0.00
Land And Improvements
69.00
+0.00%
69.00
+15.00%
60.00
+1.69%
59.00
Buildings And Improvements
2,056.00
+15.12%
1,786.00
+26.76%
1,409.00
+12.27%
1,255.00
Machinery Furniture Equipment
1,321.00
+7.66%
1,227.00
+19.82%
1,024.00
+9.64%
934.00
Goodwill And Other Intangible Assets
4,918.00
-2.11%
5,024.00
+13.28%
4,435.00
-7.08%
4,773.00
Goodwill
4,473.00
-0.09%
4,477.00
+13.06%
3,960.00
+0.20%
3,952.00
Other Intangible Assets
445.00
-18.65%
547.00
+15.16%
475.00
-42.14%
821.00
Investments And Advances
133.00
-24.00%
175.00
+6.71%
164.00
-15.90%
195.00
Other Non Current Assets
1,059.00
+16.37%
910.00
+28.53%
708.00
+3.21%
686.00
Total Liabilities Net Minority Interest
5,986.00
+0.64%
5,948.00
+20.94%
4,918.00
-5.91%
5,227.00
Current Liabilities
2,347.00
+23.85%
1,895.00
+18.22%
1,603.00
-13.86%
1,861.00
Payables And Accrued Expenses
976.00
+4.05%
938.00
+29.02%
727.00
-20.02%
909.00
Payables
570.00
+5.56%
540.00
+29.19%
418.00
-27.93%
580.00
Accounts Payable
570.00
+5.56%
540.00
+29.19%
418.00
-27.93%
580.00
Current Accrued Expenses
406.00
+2.01%
398.00
+28.80%
309.00
-6.08%
329.00
Employee Benefits
126.00
-3.08%
130.00
+26.21%
103.00
+6.19%
97.00
Pensionand Other Post Retirement Benefit Plans Current
443.00
+20.38%
368.00
-0.81%
371.00
-18.46%
455.00
Current Debt And Capital Lease Obligation
304.00
+575.56%
45.00
—
36.00
Current Debt
304.00
+575.56%
45.00
—
36.00
Current Deferred Liabilities
624.00
+14.71%
544.00
+7.72%
505.00
+9.54%
461.00
Current Deferred Revenue
624.00
+14.71%
544.00
+7.72%
505.00
+9.54%
461.00
Total Non Current Liabilities Net Minority Interest
3,639.00
-10.21%
4,053.00
+22.26%
3,315.00
-1.52%
3,366.00
Long Term Debt And Capital Lease Obligation
3,050.00
-8.82%
3,345.00
+22.30%
2,735.00
+0.07%
2,733.00
Long Term Debt
3,050.00
-8.82%
3,345.00
+22.30%
2,735.00
+0.07%
2,733.00
Non Current Pension And Other Postretirement Benefit Plans
126.00
-3.08%
130.00
+26.21%
103.00
+6.19%
97.00
Other Non Current Liabilities
463.00
-19.90%
578.00
+21.17%
477.00
-11.01%
536.00
Stockholders Equity
6,741.00
+14.29%
5,898.00
+0.91%
5,845.00
+10.18%
5,305.00
Common Stock Equity
6,741.00
+14.29%
5,898.00
+0.91%
5,845.00
+10.18%
5,305.00
Capital Stock
3.00
+0.00%
3.00
+0.00%
3.00
+0.00%
3.00
Common Stock
3.00
+0.00%
3.00
+0.00%
3.00
+0.00%
3.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
283.05
-0.75%
285.19
-2.37%
292.12
-0.98%
295.00
Ordinary Shares Number
283.05
-0.75%
285.19
-2.37%
292.12
-0.98%
295.00
Additional Paid In Capital
5,575.00
+2.29%
5,450.00
+1.17%
5,387.00
+1.16%
5,325.00
Retained Earnings
1,389.00
+85.20%
750.00
-4.09%
782.00
+141.36%
324.00
Gains Losses Not Affecting Retained Earnings
-226.00
+25.90%
-305.00
+6.73%
-327.00
+5.76%
-347.00
Other Equity Adjustments
-226.00
+25.90%
-305.00
+6.73%
-327.00
+5.76%
-347.00
Total Equity Gross Minority Interest
6,741.00
+14.29%
5,898.00
+0.91%
5,845.00
+10.18%
5,305.00
Total Capitalization
9,791.00
+5.93%
9,243.00
+7.73%
8,580.00
+6.74%
8,038.00
Working Capital
2,247.00
+8.87%
2,064.00
-20.09%
2,583.00
+34.74%
1,917.00
Invested Capital
10,095.00
+8.69%
9,288.00
+8.25%
8,580.00
+6.27%
8,074.00
Total Debt
3,354.00
-1.06%
3,390.00
+23.95%
2,735.00
-1.23%
2,769.00
Net Debt
1,565.00
-24.07%
2,061.00
+80.00%
1,145.00
-33.28%
1,716.00
Net Tangible Assets
1,823.00
+108.58%
874.00
-38.01%
1,410.00
+165.04%
532.00
Tangible Book Value
1,823.00
+108.58%
874.00
-38.01%
1,410.00
+165.04%
532.00
Commercial Paper
—
—
—
—
Line Item Trend 2025-10-31 2024-10-31 2023-10-31 2022-10-31
Operating Cash Flow
1,559.00
-10.97%
1,751.00
-1.19%
1,772.00
+35.06%
1,312.00
Cash Flow From Continuing Operating Activities
1,559.00
-10.97%
1,751.00
-1.19%
1,772.00
+35.06%
1,312.00
Net Income From Continuing Operations
1,303.00
+1.09%
1,289.00
+3.95%
1,240.00
-1.12%
1,254.00
Depreciation Amortization Depletion
288.00
+12.06%
257.00
-5.17%
271.00
-14.51%
317.00
Depreciation And Amortization
288.00
+12.06%
257.00
-5.17%
271.00
-14.51%
317.00
Other Non Cash Items
50.00
+13.64%
44.00
-6.38%
47.00
+370.00%
10.00
Stock Based Compensation
128.00
-0.78%
129.00
+16.22%
111.00
-11.20%
125.00
Asset Impairment Charge
15.00
-21.05%
19.00
-93.14%
277.00
0.00
Deferred Tax
-130.00
-103.13%
-64.00
-14.29%
-56.00
-800.00%
8.00
Deferred Income Tax
-130.00
-103.13%
-64.00
-14.29%
-56.00
-800.00%
8.00
Operating Gains Losses
36.00
+700.00%
-6.00
-200.00%
-2.00
-102.63%
76.00
Gain Loss On Investment Securities
36.00
+700.00%
-6.00
-114.63%
41.00
-38.81%
67.00
Change In Working Capital
-131.00
-257.83%
83.00
+171.55%
-116.00
+75.73%
-478.00
Change In Receivables
-149.00
-2228.57%
7.00
-94.70%
132.00
+141.12%
-321.00
Changes In Account Receivables
-149.00
-2228.57%
7.00
-94.70%
132.00
+141.12%
-321.00
Change In Inventory
-97.00
-385.29%
34.00
+203.03%
-33.00
+86.69%
-248.00
Change In Payables And Accrued Expense
16.00
-84.47%
103.00
+160.23%
-171.00
-241.32%
121.00
Change In Payable
16.00
-84.47%
103.00
+160.23%
-171.00
-241.32%
121.00
Change In Account Payable
16.00
-84.47%
103.00
+160.23%
-171.00
-241.32%
121.00
Change In Other Working Capital
99.00
+262.30%
-61.00
-38.64%
-44.00
-46.67%
-30.00
Investing Cash Flow
-394.00
+68.68%
-1,258.00
-305.81%
-310.00
+8.28%
-338.00
Cash Flow From Continuing Investing Activities
-394.00
+68.68%
-1,258.00
-305.81%
-310.00
+8.28%
-338.00
Net PPE Purchase And Sale
-407.00
-7.67%
-378.00
-26.85%
-298.00
-2.41%
-291.00
Purchase Of PPE
-407.00
-7.67%
-378.00
-26.85%
-298.00
-2.41%
-291.00
Sale Of PPE
—
—
0.00
0.00
Capital Expenditure
-407.00
-7.67%
-378.00
-26.85%
-298.00
-2.41%
-291.00
Net Investment Purchase And Sale
8.00
+260.00%
-5.00
-66.67%
-3.00
-133.33%
9.00
Purchase Of Investment
0.00
+100.00%
-5.00
+37.50%
-8.00
+38.46%
-13.00
Sale Of Investment
8.00
0.00
-100.00%
5.00
-77.27%
22.00
Net Business Purchase And Sale
4.00
+100.46%
-862.00
-86100.00%
-1.00
+98.08%
-52.00
Purchase Of Business
—
-862.00
-1590.20%
-51.00
+1.92%
-52.00
Gain Loss On Sale Of Business
0.00
0.00
+100.00%
-43.00
0.00
Net Intangibles Purchase And Sale
—
—
—
—
Purchase Of Intangibles
—
—
—
—
Net Other Investing Changes
1.00
+107.69%
-13.00
-62.50%
-8.00
-100.00%
-4.00
Financing Cash Flow
-715.00
+4.92%
-752.00
+19.14%
-930.00
+32.22%
-1,372.00
Cash Flow From Continuing Financing Activities
-715.00
+4.92%
-752.00
+19.14%
-930.00
+32.22%
-1,372.00
Net Issuance Payments Of Debt
-41.00
-106.44%
637.00
+1920.00%
-35.00
-234.62%
26.00
Issuance Of Debt
4.00
-99.67%
1,197.00
0.00
-100.00%
600.00
Repayment Of Debt
-3.00
+99.50%
-600.00
0.00
+100.00%
-609.00
Long Term Debt Issuance
4.00
-99.67%
1,197.00
0.00
-100.00%
600.00
Long Term Debt Payments
-3.00
+99.50%
-600.00
0.00
+100.00%
-609.00
Net Long Term Debt Issuance
1.00
-99.83%
597.00
0.00
+100.00%
-9.00
Short Term Debt Issuance
—
—
—
1,295.00
Short Term Debt Payments
—
—
—
-1,260.00
Net Short Term Debt Issuance
-42.00
-205.00%
40.00
+214.29%
-35.00
-200.00%
35.00
Net Common Stock Issuance
-425.00
+63.04%
-1,150.00
-100.00%
-575.00
+49.52%
-1,139.00
Common Stock Payments
-425.00
+63.04%
-1,150.00
-100.00%
-575.00
+49.52%
-1,139.00
Common Stock Dividend Paid
-282.00
-2.92%
-274.00
-3.40%
-265.00
-6.00%
-250.00
Cash Dividends Paid
-282.00
-2.92%
-274.00
-3.40%
-265.00
-6.00%
-250.00
Repurchase Of Capital Stock
-425.00
+63.04%
-1,150.00
-100.00%
-575.00
+49.52%
-1,139.00
Proceeds From Stock Option Exercised
72.00
-6.49%
77.00
+14.93%
67.00
+15.52%
58.00
Net Other Financing Charges
-39.00
+7.14%
-42.00
+65.57%
-122.00
-82.09%
-67.00
Changes In Cash
450.00
+273.75%
-259.00
-148.68%
532.00
+233.67%
-398.00
Effect Of Exchange Rate Changes
9.00
+550.00%
-2.00
-140.00%
5.00
+113.89%
-36.00
Beginning Cash Position
1,332.00
-16.38%
1,593.00
+50.85%
1,056.00
-29.13%
1,490.00
End Cash Position
1,791.00
+34.46%
1,332.00
-16.38%
1,593.00
+50.85%
1,056.00
Free Cash Flow
1,152.00
-16.10%
1,373.00
-6.85%
1,474.00
+44.37%
1,021.00
Interest Paid Supplemental Data
101.00
+26.25%
80.00
-10.11%
89.00
+4.71%
85.00
Income Tax Paid Supplemental Data
318.00
+1.27%
314.00
+57.79%
199.00
-28.67%
279.00
Sale Of Business
4.00
0.00
-100.00%
50.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category